Cliawaived Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 16


  • Latest Deal Type
  • Angel

  • Investors
  • 1

Cliawaived General Information


Developer of a rapid screening test designed to get diagnostic information. The company's platform helps in testing the whole blood for elevated thyroid-stimulating hormone (TSH), and provides diagnostic information from blood, urine, breath, and saliva, enabling healthcare professionals to get the fastest-growing distributors of point-of-care and rapid diagnostic supplies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Clinics/Outpatient Services
Other Industries
Managed Care
Primary Office
  • 2721 Loker Avenue West
  • Carlsbad, CA 92010
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cliawaived Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) Completed Startup
To view Cliawaived’s complete valuation and funding history, request access »

Cliawaived Executive Team (2)

Name Title Board Seat Contact Info
Timothy Drapeau Chief Executive Officer & President
Sharon Cunningham Founder
To view Cliawaived’s complete executive team members history, request access »

Cliawaived Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cliawaived Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
First Angel Network Angel Group Minority 000 0000 000000 0
To view Cliawaived’s complete investors history, request access »